Deccan Health Care Ratios

Deccan Health Care Ltd Ratios

The Deccan Health Care Ltd Ratios page provides a complete fundamental analysis of Deccan Health Care Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Deccan Health Care Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Deccan Health Care Ltd (NSE: , BSE: 542248) is currently trading at ₹6.85, with a market capitalization of ₹160.46M. As a major player in the Health technology sector and Pharmaceuticals: other industry, Deccan Health Care Ltd remains a key stock for fundamental analysis using Deccan Health Care Ltd Ratios.

Deccan Health Care Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Deccan Health Care Ltd P/E ratio currently stands at 37.64, making it one of the most tracked metrics in Deccan Health Care Ltd Ratios.

Historically, the Deccan Health Care Ltd P/E ratio has shown strong fluctuations:

• 2024: 37.64
• 2023: 34.43
• 2022: 114.58
• 2021: 174.14
• 2020: 118.50

The rising Deccan Health Care Ltd P/E ratio indicates increasing investor confidence and premium valuation.

Price to Book Ratio (P/B)

The Deccan Health Care Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 0.37.

Historical P/B trend:

• 2024: 0.37
• 2023: 0.58
• 2022: 0.57
• 2021: 0.73

Deccan Health Care Ltd shows reasonable valuation compared to its asset base.

Price to Sales Ratio (P/S)

The Deccan Health Care Ltd P/S ratio currently stands at 0.58, an important part of Deccan Health Care Ltd Ratios for revenue valuation.

Historical P/S ratio:

• 2024: 0.58
• 2023: 0.86
• 2022: 0.78
• 2021: 1.69

A stable or declining Deccan Health Care Ltd P/S ratio indicates cautious market sentiment.

Deccan Health Care Ltd Price to Cash Flow Ratio (P/CF)

The Deccan Health Care Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 0.

Historical Deccan Health Care Ltd Price to Cash Flow Ratio:

• 2024: 0
• 2023: 0
• 2022: 0
• 2021: 0
• 2020: 388.21

The declining Deccan Health Care Ltd Price to Cash Flow Ratio suggests improving cash flow strength.

Deccan Health Care Ltd Enterprise Value Ratios

Enterprise Value (EV)

The Deccan Health Care Ltd EV currently stands at ₹412.11M, representing the total company valuation including debt.

Historical EV trend:

• 2024: 412.11M
• 2023: 506.92M
• 2022: 352.81M
• 2021: 547.59M

Deccan Health Care Ltd enterprise value consolidation suggests stable valuation.

EV/EBITDA Ratio

The Deccan Health Care Ltd EV/EBITDA ratio is currently 13.08, a key metric in Deccan Health Care Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

• 2024: 13.08
• 2023: 11.72
• 2022: 17.96
• 2021: 9.73

Higher Deccan Health Care Ltd EV/EBITDA suggests premium valuation.

Deccan Health Care Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The Deccan Health Care Ltd D/E ratio is currently 0.01, reflecting leverage and financial stability.

Historical D/E:

• 2024: 0.01
• 2023: 0.02
• 2022: 0.02
• 2021: 0.02

Deccan Health Care Ltd maintains a strong balance sheet with low debt levels.

Return on Equity (ROE %)

The Deccan Health Care Ltd ROE currently stands at 1.14%, showing profitability and capital efficiency.

Historical ROE:

• 2024: 1.14
• 2023: 1.67
• 2022: 0.39
• 2021: 0.42

Declining ROE indicates pressure on profitability.

Deccan Health Care Ltd Ratios Analysis Summary

The Deccan Health Care Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Deccan Health Care Ltd stock is undervalued, fairly valued, or overvalued.

Tracking Deccan Health Care Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.